The company was formed by experts in the field of biosimilar evaluation and has established a proprietary technology platform that provides significant improvements over traditional approaches. We currently evaluating and expanding its use across a range of different formats. Beyond the technology, we are committed to implementing industry leading systems and processes to streamline operations and drive efficiencies. As a privately owned company our focus is not on short term gains and our objective is to build a healthy business that provides the best product offering to customers.